Pemphigus Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Pemphigus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Autoimmune Blistering Diseases Study

Pemphigus VulgarisPemphigus Foliaceus
University of Pennsylvania150 enrolled3 locationsNCT02753777
Recruiting
Phase 4

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

PemphigusDermatologic Disease
University Hospital, Rouen133 enrolled34 locationsNCT05898308
Recruiting

FARD (RaDiCo Cohort) (RaDiCo-FARD)

PemphigusNeurofibromatosis Type 1Ichthyosis+6 more
Institut National de la Santé Et de la Recherche Médicale, France900 enrolled15 locationsNCT05954416
Recruiting

Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients

Periodontal DiseasesPemphigus Vulgaris (PV)
Saglik Bilimleri Universitesi20 enrolled1 locationNCT07384221
Recruiting
Phase 3

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

PemphigusSteroid-resistant Pemphigus
Ono Pharmaceutical Co. Ltd34 enrolled25 locationsNCT06696716
Recruiting
Phase 1Phase 2

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Pemphigus Vulgaris
Cabaletta Bio40 enrolled13 locationsNCT04422912
Recruiting
Phase 2Phase 3

A Clinical Study of B007 in the Treatment of Pemphigus.

Pemphigus
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled12 locationsNCT06454357
Recruiting
Phase 1

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Rheumatoid ArthritisPemphigus VulgarisSystemic Lupus Erythematosus+1 more
IRIS Research and Development, LLC30 enrolled1 locationNCT06581562
Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

CancerLymphomaLeukemia+44 more
Sanguine Biosciences20,000 enrolled1 locationNCT05635266
Recruiting

A Two-Part Study to Assess the Effects of Ritonavir on PRN1008 Pharmacokinetics, and the Effect of PRN1008 on QTc Interval Compared to Placebo and Moxifloxacin in Healthy Participants

PemphigusImmune Thrombocytopenic Purpura
Principia Biopharma, Inc.40 enrolled1 locationACTRN12618001036202